Lung/Thoracic Oncology News & Articles

61 TMEPAI regulates EMT in lung cancer cells by modulating the ROS and IRS-1 signaling pathways Carcinogenesis, June 13, 2013    Clinical Article

62 Metabolic alterations in lung cancer–associated fibroblasts correlated with increased glycolytic metabolism of the tumor Molecular Cancer Research, June 13, 2013    Clinical Article

63 Spiritual well-being in lung cancer survivors Supportive Care in Cancer, June 13, 2013    Review Article    Clinical Article

64 Association between the XRCC3 C241T polymorphism and lung cancer risk in the Asian population Tumor Biology, June 13, 2013    Evidence Based Medicine    Review Article

65 The impact of cigarette smoking on the frequency of and qualitative differences in kras mutations in korean patients with lung adenocarcinoma Full Text Yonsei Medical Journal, June 13, 2013    Clinical Article

66 Pharmacogenomic assessment of outcomes of pemetrexed-treated patients with adenocarcinoma of the lung Full Text Yonsei Medical Journal, June 13, 2013    Clinical Article

67 Radiotherapy promises: focus on lung cancer Bulletin du Cancer, June 13, 2013    Clinical Article

68 The hsp90 inhibitor nvp-auy922 potently inhibits non–small cell lung cancer growth Molecular Cancer Therapeutics, June 13, 2013    Clinical Article

69 Hgf as a circulating biomarker of onartuzumab treatment in patients with advanced solid tumors Molecular Cancer Therapeutics, June 13, 2013    Clinical Article

70 Epigenetic therapy in lung cancer Frontiers in Oncology, June 13, 2013    Review Article

71 The increment in standardized uptake value determined using dual-phase 18F-FDG PET is a promising prognostic factor in non-small-cell lung cancer European Journal of Nuclear Medicine & Molecular Imaging, June 13, 2013    Clinical Article

72 Extensive ossification of thymoma in a child Annals of Thoracic Surgery, June 13, 2013

73 Predictive models for customizing chemotherapy in advanced non-small cell lung cancer (NSCLC) Full Text Translational Lung Cancer Research, June 13, 2013

74 USP8 is a novel target for overcoming gefitinib-resistance in lung cancer Clinical Cancer Research, June 12, 2013

75 Plasma sphingolipids as markers of future lung cancer risk: A population-based, nested case-control study Cancer Epidemiology, Biomarkers & Prevention, June 12, 2013

76 Underuse of hospice care by medicaid-insured patients with stage IV lung cancer in New York and California Journal of Clinical Oncology, June 12, 2013    Clinical Article

77 Treatment of multiple primary lung cancers using stereotactic radiotherapy, either with or without surgery Radiotherapy & Oncology, June 12, 2013    Clinical Article

78 Different impact of il10 haplotype on prognosis in lung squamous cell carcinoma and adenocarcinoma Anticancer Research, June 12, 2013    Clinical Article

79 Carboxy-terminal telopeptide (CTX) and amino-terminal propeptide (PINP) of type i collagen as markers of bone metastases in patients with non-small cell lung cancer Anticancer Research, June 12, 2013    Clinical Article

80 Feedback loop between p66Shc and Nrf2 promotes lung cancer progression Cancer Letters, June 12, 2013    Clinical Article

1 Pemetrexed versus erlotinib in pretreated patients with advanced non-small cell lung cancer: A Hellenic Oncology Research Group (HORG) randomized phase 3 study Cancer, May 13, 2013

2 Intratumour variation of biomarker expression by immunohistochemistry in resectable non-small cell lung cancer European Journal of Cancer, May 6, 2013

3 The optimal duration of vitamin supplementation prior to the first dose of pemetrexed in patients with non-small-cell lung cancer Lung Cancer, May 20, 2013    Review Article

4 Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer Journal of Clinical Oncology, May 17, 2013

5 Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients data The Lancet Oncology, May 15, 2013    Review Article

6 Magnetic Resonance Imaging for Lung Cancer Journal of Thoracic Imaging, April 29, 2013    Review Article

7 Phase 2 study of sorafenib in malignant mesothelioma previously treated with platinum-containing chemotherapy Journal of Thoracic Oncology, May 21, 2013

8 Accelerated hyperfractionated radiotherapy within trimodality therapy concepts for stage IIIA/B non-small cell lung cancer: Markedly higher rate of pathologic complete remissions than with conventional fractionation European Journal of Cancer, April 26, 2013

9 Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: The CAPPA-2 study Lung Cancer, May 8, 2013

10 Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study The Lancet Oncology, May 3, 2013

11 Real-World Effectiveness of Systemic Agents Approved for Advanced Non-Small Cell Lung Cancer: A SEER-Medicare Analysis The Oncologist, May 6, 2013    Free full text

12 Randomized phase II trial of uracil/tegafur and cisplatin versus vinorelbine and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-small-cell lung cancer: NJLCG 0601 Lung Cancer, May 7, 2013

13 Anaplastic lymphoma kinase (ALK) gene rearrangement in non-small cell lung cancer (NSCLC): Results of a multi-centre ALK-testing Lung Cancer, May 16, 2013

14 The ubiquitin-CXCR4 axis plays an important role in acute lung-infection-enhanced lung tumor metastasis Clinical Cancer Research, May 23, 2013

15 Proposal on incorporating blood vessel invasion into the T classification parts as a practical staging system for stage I non-small cell lung cancer Lung Cancer, May 16, 2013

16 Impact of EGFR Inhibitor in Non-Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis Journal of the National Cancer Institute, April 19, 2013    Evidence Based Medicine

17 Variability in the treatment of elderly patients with stage IIIa (n2) non-small-cell lung cancer Journal of Thoracic Oncology, May 20, 2013

18 A phase I pharmacokinetic study of matuzumab in combination with paclitaxel in patients with EGFR-expressing advanced non-small cell lung cancer Investigational New Drugs, May 8, 2013

19 Role of ultrasound-guided transbronchial biopsy in the diagnosis of peripheral pulmonary lesions Lung Cancer, May 6, 2013

20 Randomized international phase III trial of ERCC1 and RRM1 expression-based chemotherapy versus gemcitabine/carboplatin in advanced non-small-cell lung cancer Journal of Clinical Oncology, May 24, 2013